WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Ownership - Who owns Roivant Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Roivant Sciences Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric VenkerPresident Immunovant CEO2026-01-12200,000$21.92
$4.38MSell
Eric VenkerPresident Immunovant CEO2026-01-12200,000$3.85
$770.00kBuy
Mayukh SukhatmePresident CIO2025-12-311,430,882$21.71
$31.06MSell
Mayukh SukhatmePresident CIO2025-12-312,449,877$12.68
$31.06MBuy
Mayukh SukhatmePresident CIO2025-12-311,018,995$21.71
$22.12MSell
Mayukh SukhatmePresident CIO2025-12-29436,485$21.74
$9.49MSell
Mayukh SukhatmePresident CIO2025-12-29748,358$12.68
$9.49MBuy
Mayukh SukhatmePresident CIO2025-12-29311,873$21.74
$6.78MSell
Eric VenkerPresident Immunovant CEO2025-12-24117,848$3.85
$453.71kBuy
Frank TortiPresident and Vant Chair2025-12-2464,891$22.47
$1.46MSell

1 of 18

ROIV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ROIV insiders and whales buy or sell their stock.

ROIV Shareholders

What type of owners hold Roivant Sciences Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Qvt Financial LP16.75%116,494,010$2.69BInsider
Daniel Allen Gold15.75%109,559,420$2.53BInsider
Dexcel Pharma Technologies Ltd14.79%102,849,443$2.38BInsider
Keith S. Manchester10.70%74,393,358$1.72BInsider
Svf Investments Uk Ltd10.50%73,031,667$1.69BInsider
Sumitomo Chemical Co Ltd10.24%71,251,083$1.65BInsider
Fmr LLC8.74%60,766,984$1.41BInstitution
Vivek Ramaswamy6.76%47,011,612$1.09BInsider
Morgan Stanley6.37%44,322,857$1.03BInstitution
Sb Investment Advisers Uk Ltd5.80%40,315,127$932.49MInstitution

1 of 3

ROIV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ROIV42.61%57.39%Net SellingNet Selling
MRNA70.28%22.74%Net BuyingNet Buying
BBIO63.47%36.53%Net SellingNet Selling
ASND100.00%0.00%
IONS96.99%3.01%Net SellingNet Selling
View Top Biotech Stocks

Roivant Sciences Stock Ownership FAQ

Who owns Roivant Sciences?

Roivant Sciences (NASDAQ: ROIV) is owned by 72.12% institutional shareholders, 97.14% Roivant Sciences insiders, and 0.00% retail investors. Qvt Financial LP is the largest individual Roivant Sciences shareholder, owning 116.49M shares representing 16.75% of the company. Qvt Financial LP's Roivant Sciences shares are currently valued at $2.68B.

If you're new to stock investing, here's how to buy Roivant Sciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.